Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Abdominal stent graft solution from Endologix gains FDA approval

Endologix, an Irvine, California-based healthcare technology company, has received FDA approval for its new abdominal stent graft solution.

Thumbnail

24-hour blood pressure assessments provide little value

When evaluating a pediatric patient for hypertension, healthcare providers often monitor the child’s blood pressure for a 24-hour period. However, according to new findings published in the Clinical Journal of the American Society of Nephrology, such “blood pressure load” assessments may not provide significant value.  

Thumbnail

Mental stress associated with repeat heart attacks, death from heart disease

The presence of mental stress is a key predictor of when MI patients may have a repeat MI or die from heart disease, according to new research highlighted by the American College of Cardiology.

What the COVID-19 pandemic means for cath labs

The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

Thumbnail

Risk of death from stroke drops 24%

The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients. 

Thumbnail

Making an impact: AHA outlines its role during COVID-19 pandemic

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

Thumbnail

HF patients with type 2 diabetes can safely be treated with liraglutide

Liraglutide, a common medication used to treat type 2 diabetes (T2D), is safe to use for heart failure (HF) patients, according to new findings published in the Journal of the American College of Cardiology.

Thumbnail

A new warning for heart patients as COVID-19 continues to spread

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.